Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1988 2
1989 1
1990 2
1991 4
1992 7
1993 4
1994 8
1995 17
1996 6
1997 4
1998 8
1999 7
2000 13
2001 11
2002 26
2003 30
2004 28
2005 28
2006 16
2007 18
2008 20
2009 18
2010 22
2011 24
2012 16
2013 13
2014 13
2015 6
2016 17
2017 20
2018 36
2019 25
2020 17
2021 28
2022 23
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28668873

498 results

Results by year

Filters applied: . Clear all
Page 1
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.
Stickel F, Jüngert B, Brueckl V, Schirner I, Brueckl WM, Männlein G, Hegewald J, Mühldorfer S, Bittorf B, Hohenberger W, Hahn EG, Wein A. Stickel F, et al. Anticancer Drugs. 2003 Oct;14(9):745-9. doi: 10.1097/00001813-200310000-00010. Anticancer Drugs. 2003. PMID: 14551509
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing.
Koucky K, Wein A, Konturek PC, Albrecht H, Reulbach U, Männlein G, Wolff K, Ostermeier N, Busse D, Golcher H, Schildberg C, Janka R, Hohenberger W, Hahn EG, Siebler J, Neurath MF, Boxberger F. Koucky K, et al. Med Sci Monit. 2011 May;17(5):CR248-58. doi: 10.12659/msm.881764. Med Sci Monit. 2011. PMID: 21525806 Free PMC article.
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kourousis C, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V. Souglakos J, et al. Dig Dis. 2007;25(1):100-5. doi: 10.1159/000099177. Dig Dis. 2007. Retraction in: Dig Dis. 2008;26(2):188. doi: 10.1159/000128588. PMID: 17384515 Free article. Retracted. Clinical Trial.
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F. Wolff K, et al. Anticancer Drugs. 2009 Mar;20(3):165-73. doi: 10.1097/CAD.0b013e32831f8ec9. Anticancer Drugs. 2009. PMID: 19125117 Clinical Trial.
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
Muro K, Boku N, Shimada Y, Tsuji A, Sameshima S, Baba H, Satoh T, Denda T, Ina K, Nishina T, Yamaguchi K, Takiuchi H, Esaki T, Tokunaga S, Kuwano H, Komatsu Y, Watanabe M, Hyodo I, Morita S, Sugihara K. Muro K, et al. Lancet Oncol. 2010 Sep;11(9):853-60. doi: 10.1016/S1470-2045(10)70181-9. Epub 2010 Aug 12. Lancet Oncol. 2010. PMID: 20708966 Clinical Trial.
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
Köhne CH, van Cutsem E, Wils J, Bokemeyer C, El-Serafi M, Lutz MP, Lorenz M, Reichardt P, Rückle-Lanz H, Frickhofen N, Fuchs R, Mergenthaler HG, Langenbuch T, Vanhoefer U, Rougier P, Voigtmann R, Müller L, Genicot B, Anak O, Nordlinger B; European Organisation for Research and Treatment of Cancer Gastrointestinal Group. Köhne CH, et al. J Clin Oncol. 2005 Aug 1;23(22):4856-65. doi: 10.1200/JCO.2005.05.546. Epub 2005 Jun 6. J Clin Oncol. 2005. PMID: 15939923 Clinical Trial.
498 results